Kantar Health has appointed Andrew Miniuks as Senior Director, Oncology Market Access Europe, leading the development of the publication of the same name and overseeing custom consulting engagements in oncology.
Miniuks joins from the National Institute for Health and Clinical Excellence (NICE) where he was was a Program Director supporting the development of professional search engine and information portal NHS Evidence. Previously he worked for Pfizer as a Strategic Development Manager tracking policy developments in the UK and their impact on commercial operations; and at AT Kearney as a management consultant in the Pharmaceuticals and Healthcare Practice. He holds a BA in Chemistry and a BS in Geology from the University of Massachusetts; an MA in Geochemistry from Boston University; and an MBA from the London Business School.
Oncology Market Access Europe is published annually and covers market access, pricing and reimbursement, and marketing and sales in the EU’s big five economies.
Patricia Ensor, R.Ph., SVP in Kantar Health's Commercial Development practice, says Miniuks’ ‘highly relevant experience in the private and public sectors’ adds to the division’s unique global oncology offer.
Kantar Health has appointed Andrew Miniuks as Senior Director, Oncology Market Access Europe, leading the development of the publication of the same name and overseeing custom consulting engagements in oncology.